New York, USA

Simon is currently Director, Scientific Communications at CHDI Foundation, Inc, a privately-funded, not-for-profit, virtual biotech company that is exclusively dedicated to rapidly discovering and developing therapies that slow the progression of Huntington’s disease (www.chdifoundation.org). He has a diverse scientific communications background, beginning in scientific publishing as an editor at Nature Medicine where he managed the peer review process for all immunology and infectious disease manuscripts. Subsequently he was Senior Director for Scientific Communications at the International AIDS Vaccine Initiative (IAVI), a non-profit research, development, and advocacy organization committed to ensuring the development of an effective AIDS vaccine. He was also the editor of IAVI Report, that organization’s publication detailing scientific progress and challenges. Prior to this he pursued a transatlantic research career that focused on virology and immunology at the Universities of Warwick and Wisconsin-Madison.